Engelsman Martijn, Remeijer Peter, van Herk Marcel, Mijnheer Ben, Damen Eugène
Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Med Phys. 2003 Jun;30(6):1086-95. doi: 10.1118/1.1573208.
To assess the benefit of beam fringe (50%-90% dose level) sharpening for lung tumors, we performed a numerical simulation in which all geometrical errors (breathing motion, random and systematic errors) are included. A 50 mm diameter lung tumor, located centrally in a lung-equivalent phantom was modeled. Treatment plans were designed with varying number and direction of beams, both with and without the use of intensity modulation to sharpen the beam fringe. Field size and prescribed dose were varied under the constraint of a constant mean lung dose of 20 Gy, which yields a predicted complication probability of about 10%. After numerical simulation of the effect of setup errors and breathing, the resulting dose distribution was evaluated using the minimum dose and the equivalent uniform dose (EUD) in the moving clinical target volume (CTV). When the dose in the CTV was constrained between 95% and 107% of the prescribed dose, the maximum attainable EUD was 71 Gy for a four-field noncoplanar technique with simple conformal beams. When penumbra sharpening was applied using a single beam segment at the edge of the open field, this EUD could be raised to 87 Gy. For a hypothetical infinitely steep penumbra, further escalation to an EUD of 104 Gy was possible. When the dose in the CTV was not constrained, a large escalation of the EUD was possible compared to the constrained case. In this case, the maximum attainable EUD for open fields was 115 Gy, using the four-field noncoplanar technique. The benefit of penumbra sharpening was only modest, with no increase of the EUD for the single-segment technique and a small increase to 125 Gy for the infinitely steep penumbra. From these results we conclude that beam fringe sharpening in combination with field-size reduction leads to a large increase in EUD when a homogeneous target dose is pursued. Further escalation of the EUD is possible when the homogeneity constrained is relaxed, but the relative benefit of beam-fringe sharpening then decreases.
为评估射束边缘(50%-90%剂量水平)锐化对肺部肿瘤的益处,我们进行了一项数值模拟,其中纳入了所有几何误差(呼吸运动、随机误差和系统误差)。模拟了一个直径50毫米的肺部肿瘤,位于等效肺模体的中心位置。设计了不同射束数量和方向的治疗计划,包括使用和不使用强度调制来锐化射束边缘的情况。在平均肺剂量恒定为20 Gy的约束条件下改变射野大小和处方剂量,这会产生约10%的预测并发症概率。在对摆位误差和呼吸的影响进行数值模拟后,使用移动临床靶区(CTV)中的最小剂量和等效均匀剂量(EUD)评估所得的剂量分布。当CTV中的剂量限制在处方剂量的95%至107%之间时,对于采用简单适形射束的四野非共面技术,可达到的最大EUD为71 Gy。当在开放射野边缘使用单个射束段进行半值层锐化时,该EUD可提高到87 Gy。对于假设的无限陡峭半值层,EUD可进一步提高到104 Gy。当CTV中的剂量不受约束时与受约束情况相比,EUD可能会大幅提高。在这种情况下,采用四野非共面技术,开放射野可达到的最大EUD为115 Gy。半值层锐化的益处仅为中等程度,单段技术的EUD没有增加,对于无限陡峭半值层,EUD小幅增加至125 Gy。从这些结果我们得出结论,当追求均匀的靶区剂量时,射束边缘锐化与射野大小减小相结合会导致EUD大幅增加。当均匀性约束放宽时,EUD有可能进一步提高,但此时射束边缘锐化的相对益处会降低。